← FDA DRUG APPROVALS

FDA ANDA · ANDA088117

TRIPROLIDINE AND PSEUDOEPHEDRINE

Sponsor: WEST WARD

APPLICATION
ANDA088117
TYPE
ANDA
LATEST ACTION
1984-10-10
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

TRIPROLIDINE AND PSEUDOEPHEDRINEDiscontinued
PSEUDOEPHEDRINE HYDROCHLORIDE 60MG, TRIPROLIDINE HYDROCHLORIDE 2.5MG · TABLET · ORAL

Approval history

1984-10-10Manufacturing (CMC) · Supplement 11AP
1984-10-10Manufacturing (CMC) · Supplement 12AP
1984-10-10Manufacturing (CMC) · Supplement 10AP
1984-05-14Manufacturing (CMC) · Supplement 5AP
1984-02-14Manufacturing (CMC) · Supplement 2AP
1983-11-03Manufacturing (CMC) · Supplement 3AP
1983-07-13Manufacturing (CMC) · Supplement 1AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →